| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 643860 | Null | 0.000316293616993019 | 0.48944913 |
| NSC 681637 | Camptothecin Derivative | 0.000316293616993019 | 0.072395751 |
| NSC 702015 | 1H-Indole-2-carboxylic acid, 2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl ester, (11aS)- | 0.000316293616993019 | 0.49689497 |
| NSC 675003 | Benzofuran-3-carboxylic acid, 2,3-dihydro-7-hydroxy- 2-(3,4-dihydroxyphenyl)-5-(3-methoxy-3-oxo-1-propen-1-yl)-, methyl ester, stereoisomer | 0.000332787192635313 | 0.3202797 |
| NSC 75890 | 1,9-Pyrazoloanthrone | 0.000332787192635313 | 0.12916601 |
| NSC 700087 | Bisoxireno[1,10a:3,4]phenanthro[3,2-b]furan-9(7aH)-one, 1,2, 3,4,4a,5,6,11a,11b,11c-decahydro-4,4,8,11c-tetramethyl-, [4aR-(4a.alpha.,6aS*,7a.beta.,10aR*,11a.beta.,11b.alpha.,11c.beta,)]- (9CI) | 0.000380874609232497 | 0.40605894 |
| NSC 237538 | 2,4-Thiazolidinedione, 5-(3-phenyl-2-propenylidene)- | 0.000483960412931737 | 0.18955897 |
| NSC 339638 | 2H-Pyran-2-one, 5,6-dihydro-6-[3,6,13-trihydroxy-3-methyl- 4-(phosphonooxy)-1,7,9,11-tridecatetraenyl]-, monosodiumsalt | 0.00057400073542549 | 0.54609412 |
| NSC 683782 | Null | 0.00057400073542549 | 0.5542182 |
| NSC 628949 | Null | 0.000778243021198128 | 0.45301761 |